Page 2509 - Hematology_ Basic Principles and Practice ( PDFDrive )

2237.e4 Part XII Hemostasis and Thrombosis

140. Dagan E, Brik R, Broza Y, et al: Henoch-Schonlein purpura: poly- 165. Vichinsky EP, Pennathur-Das R, Nickerson B, et al: Inadequate ery-
morphisms in thrombophilia genes. Pediatr Nephrol 21(8):1117–1121, throid response to hypoxia in cystic fibrosis. J Pediatr 105(1):15–21,
2006. 1984.
141. Kauffmann RH, Herrmann WA, Meyer CJ, et al: Circulating IgA- 166. Keevil B, Rowlands D, Burton I, et al: Assessment of iron status in
immune complexes in Henoch-Schonlein purpura: a longitudinal study cystic fibrosis patients. Ann Clin Biochem 37(Pt 5):662–665, 2000.
of their relationship to disease activity and vascular deposition of IgA. 167. Khalid S, McGrowder D, Kemp M, et al: The use of soluble transferin
Am J Med 69(6):859–866, 1980. receptor to assess iron deficiency in adults with cystic fibrosis. Clin
142. Giangiacomo J, Tsai CC: Dermal and glomerular deposition of IgA in Chim Acta 378(1–2):194–200, 2007.
anaphylactoid purpura. Am J Dis Child 131(9):981–983, 1977. 168. Mayer B, Yurek S, Salama A: Piperacillin-induced immune hemo-
143. Davin JC, Coppo R: Henoch-Schonlein purpura nephritis in children. lysis: new cases and a concise review of the literature. Transfusion
Nat Rev Nephrol 10(10):563–573, 2014. 50(5):1135–1138, 2010.
144. Waldo FB: Is Henoch-Schonlein purpura the systemic form of IgA 169. Chavez A, Mian A, Scurlock AM, et al: Antibiotic hypersensitivity
nephropathy? Am J Kidney Dis 12(5):373–377, 1988. in CF: drug-induced life-threatening hemolytic anemia in a pediatric
145. Heaton JM, Turner DR, Cameron JS: Localization of glomerular patient. J Cyst Fibros 9(6):433–438, 2010.
“deposits” in Henoch-Schonlein nephritis. Histopathology 1(2):93–104, 170. Kemp T, Schram-Doumont A, van Geffel R, et al: Alteration of the
1977. N-formyl-methionyl-leucyl-phenylalanine-induced response in cystic
146. Rosenblum ND, Winter HS: Steroid effects on the course of fibrosis neutrophils. Pediatr Res 20(6):520–526, 1986.
abdominal pain in children with Henoch-Schonlein purpura. Pediatrics 171. Lawrence RH, Sorrelli TC: Decreased polymorphonuclear leucocyte
79(6):1018–1021, 1987. chemotactic response to leukotriene B 4 in cystic fibrosis. Clin Exp
147. Ronkainen J, Koskimies O, Ala-Houhala M, et al: Early prednisone Immunol 89(2):321–324, 1992.
therapy in Henoch-Schonlein purpura: a randomized, double-blind, 172. Graff I, Schram-Doumont A, Szpirer C: Defective protein kinase
placebo-controlled trial. J Pediatr 149(2):241–247, 2006. C-mediated actions in cystic fibrosis neutrophils. Cell Signal 3(3):259–
148. Bergstein J, Leiser J, Andreoli SP: Response of crescentic Henoch- 266, 1991.
Schoenlein purpura nephritis to corticosteroid and azathioprine 173. Dudez TS, Chanson M, Schlegel-Haueter SE, et al: Characterization of
therapy. Clin Nephrol 49(1):9–14, 1998. a novel chemotactic factor for neutrophils in the bronchial secretions of
149. Foster BJ, Bernard C, Drummond KN, et al: Effective therapy for severe patients with cystic fibrosis. J Infect Dis 186(6):774–781, 2002.
Henoch-Schonlein purpura nephritis with prednisone and azathio- 174. Mackerness KJ, Jenkins GR, Bush A, et al: Characterisation of the range
prine: a clinical and histopathologic study. J Pediatr 136(3):370–375, of neutrophil stimulating mediators in cystic fibrosis sputum. Thorax
2000. 63(7):614–620, 2008.
150. Flynn JT, Smoyer WE, Bunchman TE, et al: Treatment of Henoch- 175. Taggart C, Coakley RJ, Greally P, et al: Increased elastase release
Schonlein purpura glomerulonephritis in children with high-dose by CF neutrophils is mediated by tumor necrosis factor-alpha and
corticosteroids plus oral cyclophosphamide. Am J Nephrol 21(2):128– interleukin-8. Am J Physiol Lung Cell Mol Physiol 278(1):L33–L41,
133, 2001. 2000.
151. Shin JI, Park JM, Shin YH, et al: Cyclosporin A therapy for severe 176. Knutsen AP, Slavin RG, Roodman ST, et al: Decreased T helper cell
Henoch-Schonlein nephritis with nephrotic syndrome. Pediatr Nephrol function in patients with cystic fibrosis. Int Arch Allergy Appl Immunol
20(8):1093–1097, 2005. 85(2):208–212, 1988.
152. Zaffanello M, Brugnara M, Franchini M: Therapy for children with 177. Verghese T, Beverley D: Vitamin K deficient bleeding in cystic fibrosis.
Henoch-Schonlein purpura nephritis: a systematic review. Scientific- Arch Dis Child 88(6):553, 2003.
WorldJournal 7:20–30, 2007. 178. Torstenson OL, Humphrey GB, Edson JR, et al: Cystic fibrosis present-
153. Donnithorne KJ, Atkinson TP, Hinze CH, et al: Rituximab therapy ing with severe hemorrhage due to vitamin K malabsorption: a report
for severe refractory chronic Henoch-Schonlein purpura. J Pediatr of three cases. Pediatrics 45(5):857–861, 1970.
155(1):136–139, 2009. 179. Merelle ME, Griffioen RW, Dankert-Roelse JE: Cystic fibrosis present-
154. Strong WB: Complications of polycythemia in patients who have ing with intracerebral haemorrhage. Lancet 358(9297):1960, 2001.
cyanotic congenital heart disease. Pediatr Rev 13(10):379–380, 1992. 180. Corrigan JJ, Jr, Taussig LM, Beckerman R, et al: Factor II (prothrom-
155. Gidding SS, Stockman JA, 3rd: Effect of iron deficiency on tissue bin) coagulant activity in immunoreactive protein: detection of vitamin
oxygen delivery in cyanotic congenital heart disease. Am J Cardiol K deficiency and liver disease in patients with cystic fibrosis. J Pediatr
61(8):605–607, 1988. 99(2):254–257, 1981.
156. West DW, Scheel JN, Stover R, et al: Iron deficiency in children with 181. Cornelissen EA, van Lieburg AF, Motohara K, et al: Vitamin K status
cyanotic congenital heart disease. J Pediatr 117(2 Pt 1):266–268, 1990. in cystic fibrosis. Acta Paediatr 81(9):658–661, 1992.
157. Kontras SB, Sirak HD, Newton WA, Jr: Hematologic abnormalities in 182. Rashid M, Durie P, Andrew M, et al: Prevalence of vitamin K deficiency
children with congenital heart disease. JAMA 195(8):611–615, 1966. in cystic fibrosis. Am J Clin Nutr 70(3):378–382, 1999.
158. Mauer HM, McCue CM, Caul J, et al: Impairment in platelet aggrega- 183. Wilson DC, Rashid M, Durie PR, et al: Treatment of vitamin K
tion in congenital heart disease. Blood 40(2):207–216, 1972. deficiency in cystic fibrosis: effectiveness of a daily fat-soluble vitamin
159. Onimoe G, Grooms L, Perdue K, et al: Acquired von Willebrand combination. J Pediatr 138(6):851–855, 2001.
syndrome in congenital heart disease: does it promote an increased 184. Borowitz D, Robinson KA, Rosenfeld M, et al: Cystic Fibrosis Founda-
bleeding risk? Br J Haematol 155:622, 2011. tion evidence-based guidelines for management of infants with cystic
160. Macdonald PD, Gibson BE, Brownlie J, et al: Protein C activity in fibrosis. J Pediatr 155(6 Suppl):S73–S93, 2009.
severely ill newborns with congenital heart disease. J Perinat Med 185. Conway SP: Vitamin K in cystic fibrosis. J R Soc Med 97(Suppl
20(6):421–427, 1992. 44):48–51, 2004.
161. Gross S, Keefer V, Liebman J: The platelets in cyanotic congenital heart 186. Raffini LJ, et al: Dramatic increase in venous thromboembolism in
disease. Pediatrics 42(4):651–658, 1968. children’s hospitals in the United States from 2001 to 2007. Pediatr
162. Ekert H, Sheers M: Preoperative and postoperative platelet func- 124(4):1001–1008, 2009.
tion in cyanotic congenital heart disease. J Thorac Cardiovasc Surg 187. Balfour-Lynn IM, Malbon K, Burman JF, et al: Thrombophilia in
67(2):184–190, 1974. children with cystic fibrosis. Pediatr Pulmonol 39(4):306–310, 2005.
163. Maurer HM, McCue CM, Robertson LW, et al: Correction of platelet 188. Barker M, Thoenes D, Dohmen H, et al: Prevalence of thrombophilia
dysfunction and bleeding in cyanotic congenital heart disease by simple and catheter-related thrombosis in cystic fibrosis. Pediatr Pulmonol
red cell volume reduction. Am J Cardiol 35(6):831–835, 1975. 39(2):156–161, 2005.
164. Dolan TF, Jr: Hemolytic anemia and edema as the initial signs in 189. Williams V, Griffiths AB, Yap ZL, et al: Increased thrombophilic
infants with cystic fibrosis: consider this diagnosis even in absence of tendency in pediatric cystic fibrosis patients. Clin Appl Thromb Hemost
pulmonary symptoms. Clin Pediatr (Phila) 15(7):597–600, 1976. 16(1):71–76, 2010.